STRATEGIC LAB PARTNERS
Deployed Applications

A large-scale national specimen collection initiative was experiencing critical supply chain delays sourcing FDA Class II collection and transport devices through legacy distribution channels. Inconsistent replenishment cycles were creating costly back-orders and threatening program continuity across dozens of collection sites.

Strategic Lab Partners was engaged to serve as a regional distribution hub, leveraging its centrally located FDA-registered Tennessee fulfillment facility and established manufacturer relationships. SLP analyzed the program's consumption cadence, pre-positioned inventory, and activated SLP CONNECT™ for real-time stock visibility and automated replenishment alerts.

A publicly traded direct-to-consumer genomics retailer faced mounting pressure to scale its consumer saliva sampling program while maintaining uncompromised DNA/RNA integrity, chain-of-custody compliance, and regulatory defensibility. Existing logistics were fragmented, with no unified system governing kit serialization, participant metadata, or last-mile tracking.

SLP engineered a fully serialized, private-labeled kitting solution using superior point-of-collection saliva devices capable of stabilizing microbial nucleic acids at ambient temperature. Every kit was assigned a unique ID within SLP CONNECT™, synchronizing barcode tracking with participant data and downstream LIMS integration. DIM Intelligence optimized package architecture, reducing per-unit freight costs across high-volume fulfillment runs.

A CRO managing a multi-site decentralized clinical trial encountered significant pre-analytical variability across its genomics, proteomics, and metabolomics collection arms. Fragmented logistics — disparate couriers, inconsistent kit contents, manual tracking — were introducing data quality risk and jeopardizing regulatory submission readiness. Redraws and specimen attrition were compounding both cost and timeline overruns.

SLP performed a full protocol-to-kit translation, converting arms, visit schedules, analyte requirements, and environmental constraints into a modular kitting architecture. Analyte-specific workflows were engineered for RNA-sensitive and cryogenic-compliant collection. SLP CONNECT™ was configured as the system of record, onboarding all sites, labs, and depot partners into a single governed environment with role-based access, automated replenishment, and real-time exception alerts.

A regional healthcare institution operating a women's health and diagnostics program was experiencing recurring specimen loss, kit stockouts, and OR scheduling disruptions traced directly to pre-analytical infrastructure gaps. Inconsistent kit contents, unreliable courier performance, and zero real-time visibility were creating downstream diagnostic delays and patient care risks.

SLP designed a standardized, institution-branded kitting solution aligned to the program's specimen types and collection protocols. The SLP CONNECT™ dashboard was deployed to give clinical coordinators real-time visibility into pending orders, in-transit shipments, active SKUs, and low-stock alerts — replacing manual reconciliation with governed operational intelligence. Courier performance was monitored through the Shipments Module with exception tracking enabling rapid intervention.

A precision medicine sponsor conducting lipidomic and glycemic biomarker discovery required precise timing windows between specimen collection and laboratory accessioning. Logistical variability — temperature deviations, undefined transit times, and unlabeled handling events — was introducing biological variance that threatened the statistical reliability of the study's mechanistic endpoints.

SLP engineered an ambient-temperature nucleic-acid stabilization kitting system and activated SLP CONNECT™'s continuous temperature monitoring and timestamp logging for every shipment. Biological variance was correlatable to logistic data, enabling the research team to isolate and account for pre-analytical contributions to endpoint variability. Automated compliance audit logs were generated within SLP CONNECT™ for FDA and sponsor review.

A southeastern clinical services organization was over-reliant on a single premium-brand specimen collection device supplier, resulting in high recurring acquisition costs, frequent back-orders, and supply chain fragility. The organization lacked visibility into alternative sourcing options that could meet equivalent or superior FDA Class I & II quality standards at a lower cost basis.

SLP conducted a supply chain analysis, demonstrating projected savings and quality equivalency before any agreement was executed. FDA Class I & II cost-efficient bulk alternative devices were identified and validated, with SLP providing a comparative ROI model showing that savings of as little as 8% on bulk orders equated to a full month's equivalent supply. Custom kitting was configured to client specifications, and SLP CONNECT™ provided ongoing order and inventory management.